🔎 Trials Near Me

Utama › Kanser Pankreas › Mississippi

Kajian klinikal Kanser Pankreas di Mississippi

5 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi di Mississippi.

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US047, Hattiesburg
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07522073

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06958328

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06998940

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University Telemedicine, Jackson
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT06906562

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Hattiesburg
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.